Abstract
Cold agglutinins are a potential danger to patients who must be subjected to hypothermia. A patient with a cold agglutinin of moderate titer but broad thermal amplitude was to undergo hypothermia during aortic valve replacement. He was managed preoperatively with an eight-liter plasma exchange by continuous-flow centrifugation to remove the cold agglutinin. There were no adverse effects during or after hypothermia.
Original language | English (US) |
---|---|
Pages (from-to) | 354-357 |
Number of pages | 4 |
Journal | Transfusion |
Volume | 20 |
Issue number | 3 |
State | Published - 1980 |
Externally published | Yes |
ASJC Scopus subject areas
- Hematology
- Immunology